- Analyst Sentiment: The average one-year price target for MNMD is $24.74, with forecasts ranging from a low of $16.16 to a high of $37.805. This indicates that analysts have a positive outlook on the stock's future performance.
- Market Performance: MNMD has a Zacks Rank of #2 (Buy), indicating that analysts expect the company to outperform the market over the next one to three months6. Additionally, the company's earnings outlook is stronger, with the Zacks Consensus Estimate for MNMD's full-year earnings having moved 19.8% higher over the past three months6.
In conclusion, while there is no specific short-term trend forecast available for MNMD, the positive 1-month percentage change, the higher forecast price, the positive analyst sentiment, and the strong market performance indicators do not suggest that Mind Medicine is expected to drop today.